DE69829881D1 - Synthetische antineoplastische wirkstoffe abgeleitet von dolastatin 15 sowie verfahren zu ihrer herstellung - Google Patents
Synthetische antineoplastische wirkstoffe abgeleitet von dolastatin 15 sowie verfahren zu ihrer herstellungInfo
- Publication number
- DE69829881D1 DE69829881D1 DE69829881T DE69829881T DE69829881D1 DE 69829881 D1 DE69829881 D1 DE 69829881D1 DE 69829881 T DE69829881 T DE 69829881T DE 69829881 T DE69829881 T DE 69829881T DE 69829881 D1 DE69829881 D1 DE 69829881D1
- Authority
- DE
- Germany
- Prior art keywords
- dolastatin
- production
- activities derived
- antineoplastic activities
- synthetic antineoplastic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- LQKSHSFQQRCAFW-UHFFFAOYSA-N Dolastatin 15 Natural products COC1=CC(=O)N(C(=O)C(OC(=O)C2N(CCC2)C(=O)C2N(CCC2)C(=O)C(C(C)C)N(C)C(=O)C(NC(=O)C(C(C)C)N(C)C)C(C)C)C(C)C)C1CC1=CC=CC=C1 LQKSHSFQQRCAFW-UHFFFAOYSA-N 0.000 title 1
- LQKSHSFQQRCAFW-CCVNJFHASA-N [(2s)-1-[(2s)-2-benzyl-3-methoxy-5-oxo-2h-pyrrol-1-yl]-3-methyl-1-oxobutan-2-yl] (2s)-1-[(2s)-1-[(2s)-2-[[(2s)-2-[[(2s)-2-(dimethylamino)-3-methylbutanoyl]amino]-3-methylbutanoyl]-methylamino]-3-methylbutanoyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carboxyl Chemical compound C([C@@H]1N(C(=O)C=C1OC)C(=O)[C@@H](OC(=O)[C@H]1N(CCC1)C(=O)[C@H]1N(CCC1)C(=O)[C@H](C(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C)C(C)C)C(C)C)C1=CC=CC=C1 LQKSHSFQQRCAFW-CCVNJFHASA-N 0.000 title 1
- 230000000118 anti-neoplastic effect Effects 0.000 title 1
- 108010045552 dolastatin 15 Proteins 0.000 title 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 3
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 abstract 1
- 125000006201 3-phenylpropyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])C([H])([H])* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical compound [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5985397P | 1997-09-24 | 1997-09-24 | |
| US59853P | 1997-09-24 | ||
| PCT/US1998/019954 WO1999015130A2 (en) | 1997-09-24 | 1998-09-23 | Synthetic antineoplastic agents derived from dolastatin 15 and methods of making same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69829881D1 true DE69829881D1 (de) | 2005-05-25 |
| DE69829881T2 DE69829881T2 (de) | 2006-03-09 |
Family
ID=22025701
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69829881T Expired - Fee Related DE69829881T2 (de) | 1997-09-24 | 1998-09-23 | Synthetische antineoplastische wirkstoffe abgeleitet von dolastatin 15 sowie verfahren zu ihrer herstellung |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1049481B1 (de) |
| JP (1) | JP2001517604A (de) |
| AT (1) | ATE293638T1 (de) |
| CA (1) | CA2298639C (de) |
| DE (1) | DE69829881T2 (de) |
| WO (1) | WO1999015130A2 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016130969A1 (en) | 2015-02-13 | 2016-08-18 | George Robert Pettit | Silstatin compounds |
| KR20240051956A (ko) | 2021-09-03 | 2024-04-22 | 도레이 카부시키가이샤 | 암의 치료 및/또는 예방용 의약 조성물 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG87056A1 (en) * | 1991-08-09 | 2002-03-19 | Teikoku Hormone Mfg Co Ltd | Novel tetrapeptide derivative |
| ATE169637T1 (de) * | 1992-05-20 | 1998-08-15 | Basf Ag | Derivate des dolastatin |
| US5780588A (en) * | 1993-01-26 | 1998-07-14 | Arizona Board Of Regents | Elucidation and synthesis of selected pentapeptides |
| US5663149A (en) * | 1994-12-13 | 1997-09-02 | Arizona Board Of Regents Acting On Behalf Of Arizona State University | Human cancer inhibitory pentapeptide heterocyclic and halophenyl amides |
| US5807984A (en) * | 1995-11-09 | 1998-09-15 | Basf Aktienegesellschaft | Oligopeptides, the preparation and use thereof |
-
1998
- 1998-09-23 JP JP2000512507A patent/JP2001517604A/ja not_active Ceased
- 1998-09-23 CA CA002298639A patent/CA2298639C/en not_active Expired - Fee Related
- 1998-09-23 DE DE69829881T patent/DE69829881T2/de not_active Expired - Fee Related
- 1998-09-23 EP EP98948504A patent/EP1049481B1/de not_active Expired - Lifetime
- 1998-09-23 AT AT98948504T patent/ATE293638T1/de not_active IP Right Cessation
- 1998-09-23 WO PCT/US1998/019954 patent/WO1999015130A2/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| JP2001517604A (ja) | 2001-10-09 |
| WO1999015130A3 (en) | 2000-08-03 |
| DE69829881T2 (de) | 2006-03-09 |
| EP1049481A2 (de) | 2000-11-08 |
| CA2298639C (en) | 2005-07-05 |
| EP1049481A4 (de) | 2001-09-12 |
| CA2298639A1 (en) | 1999-04-01 |
| WO1999015130A2 (en) | 1999-04-01 |
| EP1049481B1 (de) | 2005-04-20 |
| ATE293638T1 (de) | 2005-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE59108707D1 (de) | Verfahren zur Herstellung von Oxetanonen | |
| ATE312073T1 (de) | Sustiuierte cyclische verbindungen, verfahren zu ihrer herstellung sowie sie enthaltende pharmazeutische zusammesetzungen | |
| MX9501850A (es) | Piridilpirazoles sustituidos, procedimiento para su obtencion y composiciones pesticidas y artropodicidas que los contienen. | |
| ATE220681T1 (de) | Wasserlösliche camptothecin-derivate, verfahren zu deren herstellung und deren verwendung als antitumor-mittel | |
| ATE156818T1 (de) | Polyfluoralkylthiopoly(ethylimidazolium)- verbindungen, verfahren zu ihrer herstellung und ihre verwendung als biozide mittel | |
| YU37098A (sh) | Novi derivati eritromicina, postupci za njihovo pripremanje i njihova primena kao medikamenata | |
| DK0956033T3 (da) | Totalsyntese af amino-Hip-analogen af didemnin A | |
| IT1271325B (it) | Composti diastereomericamente puri derivati da 3-oxo e 3-tioxo-4-azaandrostani e loro uso come antiandrogeni | |
| ATE174604T1 (de) | Lipopeptide aus actinoplanes sp. mit pharmakologischer wirkung, verfahren zu ihrer herstellung und verwendung derselben | |
| ATE236139T1 (de) | Verfahren zur herstellung von 2-chlor-5- chlomethyl-thiazol-derivaten | |
| ATE266030T1 (de) | 1,4,7,10-tetraazabicyclo(8.2.2)tetradecan-2-on, verfahren zu ihrer herstellung und ihrer verwendung für die herstellung von tetraazamacrocyclen | |
| CA2228945A1 (en) | Bactericidal composition | |
| ATE457972T1 (de) | Verfahren zur herstellung von 7-amino-syn-3,5- dihydroxyheptansäurederivaten und zwischenverbindungen diesesverfahrens und deren herestellung | |
| WO2001090102A3 (de) | 6-heterocyclyl-3-oxo-3,4-dihydro-chinoxaline | |
| DE3873524D1 (de) | Iodierte polymere, verfahren zu ihrer herstellung und ihre verwendung als kontrastmittel. | |
| DE69632919D1 (de) | Verfahren zur herstellung von 2-chlor-5-chloromethyl-thiazol | |
| DE69829881D1 (de) | Synthetische antineoplastische wirkstoffe abgeleitet von dolastatin 15 sowie verfahren zu ihrer herstellung | |
| DE60105441D1 (de) | Verfahren zur herstellung von pantoprazol und zwischenprodukte dieses verfahrens | |
| ATE267799T1 (de) | Ein verfahren zur herstellung von (2s,2'r,3'r)-2- (2,3-dicarboxycyclopropyl)-glycin | |
| ATE130845T1 (de) | Verfahren zur herstellung von 3-amino-2- (het)aroyl-acrylsäurederivaten. | |
| DE69737376D1 (de) | Verfahren zur Synthese einer Oxonolverbindung | |
| ATE118521T1 (de) | Beschichtungsmasse, verfahren zu ihrer herstellung sowie deren verwendung. | |
| ATE299851T1 (de) | Verfahren zur herstellung von zwischenprodukten | |
| DE69610149D1 (de) | Verfahren zur Herstellung einer Polyphenolverbindung und positiv-arbeitende, Polyphenolverbindung enthaltende, Fotoresistzusammensetzung | |
| PT78161A (de) | Verfahren zur herstellung von 4-amino-6,7-dimethoxy-2-<4-(furo--2-yl)-piperazin-1-yl>-chinazolin und dessen physiologisch annehmabarer salze |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |